The DOI matches its Crossref record; 464 of the 476 references it cites were found in a registry or an index.
Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease
Open accessAbstract
Much thought has been given to the impact of Amyloid Beta, Tau and Alpha-Synuclein in the development of Alzheimer's disease (AD) and Parkinson's disease (PD), yet the clinical failures of the recent decades indicate that there are further pathological mechanisms at work. Indeed, besides amyloids, AD and PD are characterized by the culminative interplay of oxidative stress, mitochondrial dysfunction and hyperfission, defective autophagy and mitophagy, systemic inflammation, BBB and vascular damage, demyelination, cerebral insulin resistance, the loss of dopamine production in PD, impaired neurogenesis and, of course, widespread axonal, synaptic and neuronal degeneration that leads to cognitive and motor impediments. Interestingly, the acylated form of the hormone ghrelin has shown the potential to ameliorate the latter pathologic changes, although some studies indicate a few complications that need to be considered in the long-term administration of the hormone. As such, this review will illustrate the wide-ranging neuroprotective properties of acylated ghrelin and critically evaluate the hormone's therapeutic benefits for the treatment of AD and PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, the beneficial role of ghrelin in the central nervous system has been widely discussed, including enhanced cognition [48, 59–61].”
From Protective PLCG2 variants associate with a delayed onset of Alzheimer’s disease among heterozygous APOE ε4 carriers (2026) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–464 of 464
Effects of Ghrelin on the Proteolytic Pathways of Alzheimer’s Disease Neuronal Cells
Cecarini, V., Bonfili, L., Cuccioloni, M., Keller, J., Bruce-Keller, A., & Eleuteri, A. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9227-x · Cited by 40
Takata, A., Takiguchi, S., Miyazaki, Y., Miyata, H., Takahashi, T., Kurokawa, Y., Yamasaki, M., Nakajima, K., Mori, M., Kangawa, K., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000000986 · Cited by 40 · cited 1×
“Anti-inflammatory properties of AG have also been confirmed in various clinical studies (Kodama et al., 2008; Takata et al., 2015; Farokhnia et al., 2020).”
BackgroundAssociation between hyperleptinemia and oxidative stress in obese diabetic subjects
Pandey, G., Shihabudeen, M., David, H. P., Thirumurugan, E., & Thirumurugan, K. (2015) · Journal of Diabetes and Metabolic Disorders · doi:10.1186/s40200-015-0159-9 · Cited by 40 · cited 1×
“Thus, obesity and T2DMassociated hyperleptinemia (Maffei et al., 1995; Considine et al., 1996; Okumura et al., 2003; Pandey et al., 2015) may contribute to the desensitization of AG in the hypothalamus.”
BackgroundThe Role of Ghrelin in Neuroprotection after Ischemic Brain Injury
Spencer, S., Miller, A. A., & Andrews, Z. (2013) · Brain Science · doi:10.3390/brainsci3010344 · Cited by 40
Lee, J., Oh, T., & Yune, T. (2011) · Endocrinology · doi:10.1210/en.2011-0090 · Cited by 40 · cited 2×
“As confirmed with the utility of GHS-R1α, ERK and p38 inhibitors, an in vitro study showed that the interaction of AG with GHS-R1α on oligodendrocytes shields the cells from hydrogen peroxide (H2O2) and apoptosis by potentiating oligoprotective ERK signaling, while attenuating the pro-apoptotic activation of p38 (Lee…”
BackgroundResultFerens, D., Yin, L., Bron, R., Hunne, B., Ohashi-Doi, K., Kitchener, P. D., Sanger, G., Witherington, J., Shimizu, Y., & Furness, J. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.01.001 · Cited by 40 · cited 2×
“GHS-R1α is widely transcribed in multiple key areas of the brain, such as the hippocampus, hypothalamus, cortex, ventral tegmental area (VTA), SN, spinal cord, dorsal and median raphe nuclei, sympathetic preganglionic nerves and endothelial cells of the cerebral vasculature, yet it is also expressed by various immune…”
BackgroundGhrelin mediated neuroprotection - A possible therapy for Parkinson's disease?
Morgan, A. H., Rees, D. J., Andrews, Z. B., & Davies, J. S. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.027 · Cited by 40 · cited 1×
“Recent reports suggest a possible role for AG in the regulation of the mitochondrial fission and fusion dynamics (Morgan et al., 2018).”
BackgroundGhrelin Inhibits Oligodendrocyte Cell Death by Attenuating Microglial Activation
Lee, J. Y., & Yune, T. Y. (2014) · Endocrinology and Metabolism · doi:10.3803/enm.2014.29.3.371 · Cited by 37 · cited 3×
“While it is not entirely evident how AG inhibits NF-κB signaling in GHS-R1α-negative microglia (Moon et al., 2009a; Lee J. Y. et al., 2010; Lee and Yune, 2014), it can be assumed that the prevention of neuronal and oligodendrocyte death, leading to the reduced liberation of DAMPs, indirectly avert inflammatory process…”
BackgroundGHRELIN HYPORESPONSIVENESS CONTRIBUTES TO AGING-RELATED HYPERINFLAMMATION IN SEPTIC SHOCK
Wu, R.-Q., Zhou, M., Dong, W., Ji, Y.-X., Miksa, M., Marini, C., Ravikumar, T., & Wang, P. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181ad85d6 · Cited by 37
Li, E., Kim, Y., Kim, S., & Park, S. (2013) · Endocrine journal · doi:10.1507/endocrj.ej13-0045 · Cited by 37 · cited 3×
“, 2016), dwarf rats (Li et al., 2013), in the 6-OHDA rodent model of PD, although neurogenesis was only enhanced in the non-lesioned brain hemisphere (Elabi et al.”
BackgroundKu, J., Andrews, Z. B., Barsby, T., Reichenbach, A., Lemus, M. B., Drummond, G. R., Sleeman, M. W., Spencer, S. J., Sobey, C. G., & Miller, A. A. (2014) · Endocrinology · doi:10.1210/en.2014-1415 · Cited by 36 · cited 1×
“Although to a low degree, GHSR1α is also expressed throughout the cerebral vasculature and a markedly high density of GHS-R1α has been detected in the microvasculature of the granular layer of the cerebellum (Katugampola et al., 2001; Ku et al., 2015, 2016).”
BackgroundLee, J., Choi, H., & Yune, T. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.06.002 · Cited by 36 · cited 10×
“In a reciprocal manner, inflammation incites the microglial expression and liberation of MMP-3, initiating a wicked cycle of neuronal degeneration and neuroinflammation (Kim et al., 2005; Kim and Hwang, 2011).”
BackgroundInfluentialLiao, P.-Z., Yang, D., Liu, D., & Zheng, Y. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485820 · Cited by 36 · cited 1×
“Moreover, a recent study revealed a cytoprotective function of AG in palmitate- and glucose-stressed human microvascular endothelial cells, in which AG rescued apoptosis and caspase-3 activity by inhibiting the stress kinases p38 and JNK1/2, diminishing the mitochondrial generation of ROS and normalizing the rate of o…”
BackgroundProtein Kinase C Isozymes and Autophagy during Neurodegenerative Disease Progression
Kaleli, H. N., Ozer, E., Kaya, V. O., & Kutlu, Ö. (2020) · Cells · doi:10.3390/cells9030553 · Cited by 36
Souza-Moreira, L., Delgado-Maroto, V., Morell, M., O'Valle, F., del Moral, R. D., & González-Rey, E. (2013) · Brain, behavior, and immunity · doi:10.1016/j.bbi.2013.01.080 · Cited by 35 · cited 1×
“Immune cell invasion into the spinal cord was only blocked by AG in some of these studies, however, which might have been related to the choice of the EAE-initiating antigen used for immunization (Theil et al., 2009; Souza-Moreira et al., 2013; Liu F. et al., 2019).”
BackgroundPlasma levels of neuropeptides in Alzheimer's disease
Proto, C., Romualdi, D., Cento, R., Spada, R., Mento, G. D., Ferri, R., & Lanzone, A. (2006) · Gynecological Endocrinology · doi:10.1080/09513590500519385 · Cited by 35 · cited 1×
“While no relevant alterations in the blood levels of ghrelin have been observed in AD patients (Proto et al., 2006; Theodoropoulou et al., 2012), the basal plasma levels of ghrelin and the postprandial secretion of the hormone were diminished in PD patients (Fiszer et al.”
BackgroundBarazzoni, R., Zanetti, M., Semolic, A., Cattin, M. R., Pirulli, A., Cattin, L., & Guarnieri, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026224 · Cited by 35 · cited 1×
“, the administration of AG results in a phenotype that, despite exhibiting weight gain, displays low systemic inflammation and diminished triglyceride burden (Barazzoni et al., 2011; Garcia-Caceres et al., 2014).”
BackgroundThe Influence of Ghrelin on the Development of Dextran Sodium Sulfate-Induced Colitis in Rats
Matuszyk, A., Ceranowicz, D., Warzecha, Z., Ceranowicz, P., Fyderek, K., Gałazka, K., Cieszkowski, J., Bonior, J., Jaworek, J., Pihut, M., et al. (2015) · BioMed Research International · doi:10.1155/2015/718314 · Cited by 34 · cited 1×
“For instance, the administration of AG succeeded in the animal model of colitis, showing downregulated local and systemic release of pro-inflammatory modulators, reduced inflammatory Th 1 activity, elevated action of immunosuppressive regulatory T-cells (Tregs), diminished oxidative stress, ameliorated intestinal tiss…”
BackgroundXu, Y.-Q., Wei, X.-B., Liu, X., Liao, J., Lin, J.-P., Zhu, C.-S., Meng, X.-C., Xie, D.-X., Chao, D.-M., Fenoy, A. J., et al. (2015) · Aging and Disease · doi:10.14336/ad.2015.0204 · Cited by 34
Słupecka, M., Woliński, J., & Pierzynowski, S. (2012) · Regulatory Peptides · doi:10.1016/j.regpep.2011.11.007 · Cited by 34
Tamaki, M., Hagiwara, A., Miyashita, K., Wakino, S., Inoue, H., Fujii, K., Fujii, C., Sato, M., Mitsuishi, M., Muraki, A., et al. (2015) · Endocrinology · doi:10.1210/en.2015-1353 · Cited by 33 · cited 1×
“The activation of SIRT1 via AG has been confirmed in the periphery (Fujimura et al., 2014; Tamaki et al., 2015; Fujitsuka et al., 2016; Yang et al., 2016) as well as the hypothalamus in adult rodents and mouse models of aging (Velasquez et al.”
BackgroundUse of Ghrelin as a Treatment for Inflammatory Bowel Disease: Mechanistic Considerations
DeBoer, M. D. (2011) · International Journal of Peptides · doi:10.1155/2011/189242 · Cited by 32 · cited 4×
“…has consistently performed well in animal models of various inflammatory conditions, guarding against endotoxemia/sepsis, pancreatic, hepatic and kidney disease, cardiovascular conditions, arteriosclerosis, colitis, arthritis, age-induced inflammation and more (Baatar et al., 2011; Deboer, 2011).”
BackgroundInfluentialKu, J., Taher, M., Chin, K.-Y., Barsby, T., Austin, V., Wong, C. H. Y., Andrews, Z., Spencer, S., & Miller, A. A. (2016) · Clinical science · doi:10.1042/cs20160077 · Cited by 32
Najem, D., Bamji‐Mirza, M., Yang, Z., & Zhang, W. (2016) · Neuroscience Bulletin · doi:10.1007/s12264-016-0034-9 · Cited by 32 · cited 29×
“The NTS, on the other hand, further projects across the entirety of the CNS, ultimately leading to the intestinal return of immune-suppressing signals through the afferent ends of the vagal nerve.”
BackgroundInfluentialGarcía-Cáceres, C., Fuente-Martín, E., Díaz, F., Granado, M., Argente-Arizón, P., Frago, L., Freire-Regatillo, A., Barrios, V., Argente, J., & Chowen, J. (2014) · Endocrinology · doi:10.1210/en.2014-1074 · Cited by 30 · cited 4×
“The elevated hypothalamic synthesis of IGF-1 was also observed in AG or GHRP-6-injected obese rodents that were placed on a high fat dietary regiment (Garcia-Caceres et al., 2014).”
BackgroundInfluentialKappeler, L., Zizzari, P., Alliot, J., Epelbaum, J., & Bluet-Pajot, M. (2005) · Neuroendocrinology · doi:10.1159/000083610 · Cited by 30 · cited 1×
“The decreased sensitivity toward AG could be related to an age-induced decline in the transcriptional levels of GHS-R1α, as reported for the anterior pituitary in 24-month-old Lou C/Jall rats, the vagal nerve in aged Fischer-344 rats and the brainstem in rats and dwarf rats (Katayama et al., 2000; Kappeler et al., 200…”
1 (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.02.003 · Cited by 30 · cited 2×
“…APPswe/PS1dE9 mice displayed reduced hippocampal levels of the catalytic α2-subunit of 5’ adenosinemonophosphateactivated protein kinase (AMPK) (Pedros et al., 2014), which is a master effector that upregulates ATP synthesis, curbs ATP utility, maintains the mitochondrial homeostasis and…”
BackgroundZhou, M., Yang, W., Aziz, M., Ma, G., & Wang, P. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.01.014 · Cited by 30 · cited 1×
“, 2016), GH (Wu et al., 2009b; Zhou et al., 2017), insulin (Granado et al.”
Fisher, Y., Nemirovsky, A., Baron, R., & Monsonego, A. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-102034 · Cited by 29 · cited 1×
“Subsequent peripheral inflammatory responses by antigenpresenting cells and lymphocytes (T-cells) then induce immune entry into the CNS in AD and PD (Fisher et al., 2011; Anderson et al., 2014).”
BackgroundGhrelin alleviates spinal cord injury in rats via its anti-inflammatory effects.
Erşahin, M., Toklu, H., Erzik, C., Akakın, D., Tetik, Ş., Şener, G., & Yeg̃en, B. (2011) · Turkish Neurosurgery · doi:10.5137/1019-5149.jtn · Cited by 29
Ceranowicz, P., Warzecha, Z., Cieszkowski, J., Ceranowicz, D., Kuśnierz-Cabala, B., Bonior, J., Jaworek, J., Ambroży, T., Gil, K., Olszanecki, R., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061118 · Cited by 28
Ghrelin reverses experimental diabetic neuropathy in mice.
Kyoraku, I., Shiomi, K., Kangawa, K., & Nakazato, M. (2009) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2009.08.171 · Cited by 28 · cited 2×
“On the other hand, the injection of AG worsened glucose tolerance directly after administration, yet had rather beneficial metabolic long-term consequences, including weight loss, in T1DM, AD, and HD in vivo models (Granado et al., 2009; Kyoraku et al., 2009; Kunath et al., 2015; Duarte et al., 2018).”
BackgroundGhrelin treatment protects lactotrophs from apoptosis in the pituitary of diabetic rats
Granado, M., Chowen, J. A., García‐Cáceres, C., Delgado-Rubín, A., Barrios, V., Castillero, E., Argente, J., & Frago, L. M. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.06.006 · Cited by 26 · cited 1×
“On the other hand, the injection of AG worsened glucose tolerance directly after administration, yet had rather beneficial metabolic long-term consequences, including weight loss, in T1DM, AD, and HD in vivo models (Granado et al., 2009; Kyoraku et al., 2009; Kunath et al., 2015; Duarte et al., 2018).”
BackgroundYu, J., Xu, H.-M., Shen, X.-L., & Jiang, H. (2016) · Neuropeptides · doi:10.1016/j.npep.2015.09.011 · Cited by 26 · cited 2×
“complex 1 and prevented the toxin-induced drop in the mitochondrial membrane potential, resulting in the lessened leakage of the apoptosis-prompting cytochrome C, reduced caspase-3 activation and diminished cell death (Yu et al., 2016).”
BackgroundGrowth hormone-releasing peptide-6 inhibits cerebellar cell death in aged rats
Pañeda, C., Arroba, A., Frago, L., Holm, A., Rømer, J., Argente, J., & Chowen, J. (2003) · NeuroReport · doi:10.1097/00001756-200308260-00018 · Cited by 26 · cited 1×
“And indeed, the administration of GHRP-6 to old rats ameliorated the age-associated decline in IGF-1 levels in the cerebellum, inhibited caspase 9/3 and reduced cerebellar apoptosis (Paneda et al., 2003).”
BackgroundHeshmati, M., Soltani, A., Sanaei, M., Nahid‐Samiei, M., Shirzad, H., Jami, M., & Ghatrehsamani, M. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109492 · Cited by 26 · cited 2×
“In agreement, AG elicits AMPK-evoked autophagy in the lymphoblastic Jurkat and Molt-4 cell lines (Heshmati et al., 2020), also considering that autophagy is initiated by the inactivation of mTOR (Lan et al.”
BackgroundGhrelin stimulates fatty acid oxidation and inhibits lipolysis in isolated muscle from male rats
Kraft, E. N., Cervone, D. T., & Dyck, D. (2019) · Physiological Reports · doi:10.14814/phy2.14028 · Cited by 25 · cited 1×
“In stark contrast, AG enhanced fatty acid oxidation and lipolysis in mouse skeletal muscles (Kraft et al., 2019).”
BackgroundKenny, R., Cai, G., Bayliss, J., Clarke, M., Choo, Y. L., Miller, A. A., Andrews, Z., & Spencer, S. (2013) · American Journal of Physiology. Regulatory Integrative and Comparative Physiology · doi:10.1152/ajpregu.00594.2012 · Cited by 25 · cited 1×
“, 2009a), following various forms of ischemic CNS/spinal cord injury (SCI) in rodents (Ersahin et al., 2010, 2011; Lee J. Y. et al., 2010; Cheyuo et al., 2011; Kenny et al., 2013; Lee et al., 2014b, 2015), as well as drug-induced excitotoxicity (Lee J.”
BackgroundDuarte, A. I., Sjögren, M., Santos, M. S., Oliveira, C. R., Moreira, P. I., & Björkqvist, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-27121-w · Cited by 25 · cited 5×
“To further enhance efficacy, the combination of ghrelin agonists with other growth factors, such as EGF (Barco et al., 2011, del Barco et al., 2011, del Barco-Herrera et al., 2013; Subiros et al., 2016), GH (Wu et al., 2009b; Zhou et al., 2017), insulin (Granado et al., 2011) and GLP-1 (Duarte et al., 2018), or DAG, t…”
BackgroundMethodInfluentialLiu, S.-W., Chen, S., Ren, J., Li, B.-J., & Qin, B. (2017) · Neuropeptides · doi:10.1016/j.npep.2017.11.007 · Cited by 24 · cited 1×
“, 2016), rotenone-burdened rat retinal ganglion cells (Liu et al., 2018) and primary hypothalamic neurons during oxygen and glucose withdrawal (Chung et al.”
BackgroundBerlanga‐Acosta, J., Abreu-Cruz, A., Herrera, D. G. D. B., Mendoza‐Marí, Y., Rodríguez‐Ulloa, A., Ojalvo, A. G., Falcón‐Cama, V., Hernández‐Bernal, F., Beichen, Q., & Guillén, G. E. (2017) · Clinical Medicine Insights Cardiology · doi:10.1177/1179546817694558 · Cited by 24 · cited 2×
“Intriguingly, some ghrelin agonists show affinity toward both GHS-R1α and CD36, for example hexarelin or GHRS-6 (Demers et al., 2004; Berlanga-Acosta et al., 2017).”
BackgroundRestoration of metabolic inflammation-related ghrelin resistance by weight loss
Naznin, F., Toshinai, K., Waise, T. M. Z., Okada, T., Sakoda, H., & Nakazato, M. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0192 · Cited by 24 · cited 1×
“In line with this theory, caloric restriction and the associated weight loss ameliorated these inflammatory changes, thus restoring the sensitivity toward AG (Naznin et al., 2018).”
BackgroundGhrelin Causes a Decline in GABA Release by Reducing Fatty Acid Oxidation in Cortex
Mir, J. F., Zagmutt, S., Lichtenstein, M. P., García‐Villoria, J., Weber, M., Gracia, A., Fabriàs, G., Casas, J., López, M., Casals, N., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0921-3 · Cited by 24 · cited 1×
“Moreover, under physiological conditions, AG was shown to discourage, rather than elevate, fatty acid oxidation in the hypothalamic ARC and in the cortex (Lage et al., 2010; Gao et al., 2013; Mir et al., 2018).”
BackgroundWang, L.-X., Murphy, N., Stengel, A., Goebel-Stengel, M., Pierre, D. L. S., Maidment, N. T., & Taché, Y. (2012) · Neurogastroenterology and Motility · doi:10.1111/j.1365-2982.2012.01904.x · Cited by 23 · cited 3×
“This resulted in markedly enhanced plasma levels of L-dopa and dopamine, indicating that ghrelin may improve the gastrointestinal absorption of dopamine replacement drugs (Wang et al., 2012).”
BackgroundGarcía-del-Barco, D., Pérez-Saad, H., Rodríguez, V., Marín, J., Falcón, V., Martín, J., Cibrian, D., & Berlanga, J. (2010) · Neurotoxicity research · doi:10.1007/s12640-010-9160-8 · Cited by 23
Farokhnia, M., Portelli, J., Lee, M. R., McDiarmid, G. R., Munjal, V., Abshire, K. M., Battista, J. T., Browning, B. D., Deschaine, S. L., Akhlaghi, F., et al. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146851 · Cited by 23 · cited 1×
“Anti-inflammatory properties of AG have also been confirmed in various clinical studies (Kodama et al., 2008; Takata et al., 2015; Farokhnia et al., 2020).”
BackgroundErratum: T cells from patients with Parkinson’s disease recognize α-synuclein peptides
Sulzer, D., Alcalay, R. N., Garretti, F., COTE, L. J., Kanter, E., Agin‐Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W. H., Mao, X., et al. (2017) · Nature · doi:10.1038/nature23896 · Cited by 22 · cited 1×
“In addition, heightened numbers of partially α-synuclein-reactive Th17 cells were discovered in the blood of PD patients (Sulzer et al., 2017); to the degree that PD has been postulated as an α-synuclein-reactive autoimmune disease (Benner et al.”
BackgroundLuca, S. D., Ziko, I., Dhuna, K., Sominsky, L., Tolcos, M., Stokes, L., & Spencer, S. (2017) · Journal of neuroendocrinology · doi:10.1111/jne.12540 · Cited by 21
Yang, S., Lin, S., Chen, Y., Wu, V., Yang, W., & Wu, K. (2016) · Scientific Reports · doi:10.1038/srep32787 · Cited by 21 · cited 1×
“Furthermore, cAMP/PKA-signaling is evoked by the physiological release of AG-counteracting and growth-promoting hormones that are associated with nutrient abundance and increased glucose metabolism, such as insulin and leptin (Yang and Yang, 2016).”
BackgroundZhao, W., Wang, J., Varghese, M., Ho, L., Mazzola, P., Haroutunian, V., Katsel, P., Gibson, G., Levine, S., Dubner, L., et al. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s74898 · Cited by 20 · cited 2×
“Furthermore, quantitative microarray RNA studies have revealed that AD patients, prior to the appearance of other neuropathological hallmarks, including Aß plaques and Tau neurofibrillary tangles, exhibit a decline in the cerebral expression of insulin-regulated genes that drive TCA and pyruvate metabolism (Zhao et al…”
BackgroundSKF 83566 attenuates the effects of ghrelin on performance in the object location memory task.
Jacoby, S., & Currie, P. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.09.056 · Cited by 20 · cited 1×
“Moreover, the injection of SKF 83566 itself did not negatively affect the behavioral performance of the rodents (Jacoby and Currie, 2011).”
BackgroundGarcía-del-Barco-Herrera, D., Martínez, N. S., Coro-Antich, R. M., Machado, J. M., Alba, J. S., Salgueiro, S., & Acosta, J. A. B. (2013) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-120262 · Cited by 19 · cited 1×
“…enhance efficacy, the combination of ghrelin agonists with other growth factors, such as EGF (Barco et al., 2011, del Barco et al., 2011, del Barco-Herrera et al., 2013; Subiros et al., 2016), GH (Wu et al., 2009b; Zhou et al., 2017), insulin (Granado et al., 2011) and GLP-1 (Duarte et al.,…”
Backgrounddel Barco, D. G., Montero, E., Coro-Antich, R. M., Brown, E., Suárez-Alba, J., Lopez, L., Subirós, N., & Berlanga, J. (2011) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-2011-0595 · Cited by 18
Hong, S. W., Chun, J., Kim, J., Lee, J., Lee, H. J., Chung, H., Cho, S.-J., Im, J., Kim, S. G., & Kim, J. S. (2019) · Gut and Liver · doi:10.5009/gnl19103 · Cited by 18 · cited 2×
“As such, while AG can evidently improve gastrointestinal dysfunction (Hong et al., 2019), the occurrence of unwanted gastrointestinal side-effects in some PD patients may restrict the administration of ghrelin agonists in the long-term.”
BackgroundResultOkumura, T., Taniguchi, A., Nagasaka, S., Sakai, M., Fukushima, M., Kuroe, A., Yoshii, S., Nakamura, T., Ogura, M., Atarashi, T., et al. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70002-2 · Cited by 18 · cited 1×
“Thus, obesity and T2DMassociated hyperleptinemia (Maffei et al., 1995; Considine et al., 1996; Okumura et al., 2003; Pandey et al., 2015) may contribute to the desensitization of AG in the hypothalamus.”
BackgroundGranado, M., García-Cáceres, C., Tuda, M., Frago, L., Chowen, J., & Argente, J. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.02.002 · Cited by 13 · cited 1×
“, 2017), insulin (Granado et al., 2011) and GLP-1 (Duarte et al.”
Suda, Y., Kuzumaki, N., Narita, M., Hamada, Y., Shibasaki, M., Tanaka, K., Tamura, H., Kawamura, T., Kondo, T., Yamanaka, A., et al. (2018) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2018.01.145 · Cited by 12 · cited 3×
“Furthermore, the reduced expression of GHS-R1α was verified in induced pluripotent stem cells with a mutated or disrupted PARK2 gene, which is a mitochondrial gene implicated in mitochondrial quality control, mitophagy, and the development of early-onset PD (Pickrell and Youle, 2015), and in the SNpc of an in vivo mod…”
BackgroundProtective effects of ghrelin on brain mitochondria after cardiac arrest and resuscitation
Xu, H., Li, Y., Liu, R., Wu, L., Zhang, C., Ding, N., Ma, A., Zhang, J., & Xie, X. (2019) · Neuropeptides · doi:10.1016/j.npep.2019.05.007 · Cited by 12
Zhang, R. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.2977 · Cited by 10 · cited 3×
“…and reduced the TNF-α-incited adhesion of co-cultured monocytes/macrophages to the vascular endothelial cells, which was presumably related to the endothelial downregulation of vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule 1 (ICAM-1) (Li et al., 2004; Zhang, 2017).”
BackgroundGhrelin ameliorates blood–brain barrier disruption during systemic hypoxia
Mohaddes, G., Abdolalizadeh, J., Babri, S., & Hossienzadeh, F. (2017) · Experimental Physiology · doi:10.1113/ep086068 · Cited by 10
Subirós, N., Pérez-Saad, H., Berlanga, J., Aldana, L., García-Illera, G., Gibson, C., & García-del-Barco, D. (2016) · Neurological Research · doi:10.1179/1743132815y.0000000089 · Cited by 10 · cited 2×
“To further enhance efficacy, the combination of ghrelin agonists with other growth factors, such as EGF (Barco et al., 2011, del Barco et al., 2011, del Barco-Herrera et al., 2013; Subiros et al., 2016), GH (Wu et al., 2009b; Zhou et al., 2017), insulin (Granado et al., 2011) and GLP-1 (Duarte et al., 2018), or DAG, t…”
BackgroundParkinson disease is a TH17 dominant autoimmune disorder against accumulated alpha-synucleinPreprint
Hu, W.-C. (2011) · Nature Precedings · doi:10.1038/npre.2011.6176.1 · Cited by 9 · cited 2×
“, 2017); to the degree that PD has been postulated as an α-synuclein-reactive autoimmune disease (Benner et al., 2008; Hu, 2011).”
BackgroundElabi, O., Duskova, K., Davies, J. S., & Lane, E. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.10.045 · Cited by 7 · cited 2×
“, 2013), in the 6-OHDA rodent model of PD, although neurogenesis was only enhanced in the non-lesioned brain hemisphere (Elabi et al., 2018), and the 5xFAD animal model of AD (Moon et al.”
BackgroundInsulin and Insulin‐Like Growth Factor
Levine, T., & Levine, A. (2012) · Wiley eBooks · doi:10.1002/9781118480045.ch5 · Cited by 1 · cited 2×
“…for AD and PD, it is no surprise that its early desensitization in the CNS, believed to predominantly occur in response to chronic inflammation, promotes the development of AD and PD (see Holscher, 2019 for further information) (Blazquez et al., 2014; Werner and LeRoith, 2014; Holscher, 2020).”
Background
Flagged first, then by citations
12 of the 476 references couldn’t be matched to a known paper.
Research works printed but not linked: 7
- Jerlhag, 2010, Ghrelin receptor antagonism attenuates cocaine- and amphetamine-induced locomotor stimulation, accumbal dopamine release, and conditioned place preference, Psychopharmacology, 211, 415, 10.1007/s00213-010-1907-7 · DOI
- Konturek, 2009, Ghrelin ameliorates colonic inflammation. role of nitric oxide and sensory nerves, J. Physiol. Pharmacol, 60, 41
- Majumder, 2011, Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits, PLoS ONE, 6, e25416, 10.1371/journal.pone.0025416 · DOI · Paper page
- Mao, 2015, Ghrelin attenuated lipotoxicity via autophagy induction and nuclear factor-kappa B inhibition, Cell. Physiol. Biochem., 37, 563, 10.1159/000430377 · DOI
- Poewe, 2017, Parkinson disease, Nat. Rev. Dis., 3, 17013, 10.1038/nrdp.2017.13 · DOI · Paper page
- Yokochi, 2007, Mesolimbic and mesocortical pathways in parkinson disease, Brain Nerve 59, 943, 10.11477/mf.1416100129 · DOI
- Zhang, 2008, Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity, Cell, 135, 61, 10.1016/j.cell.2008.07.043 · DOI · Paper page
Cited by
Sorted by citations
Reich, N., & Hölscher, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.970925 · Cited by 248
Self-citationAcetyl-CoA Metabolism and Histone Acetylation in the Regulation of Aging and Lifespan
Bradshaw, P. C. (2021) · Antioxidants · doi:10.3390/antiox10040572 · Cited by 189
“Ghrelin has shown efficacy for the treatment of several mouse models of neurodegenerative disease consistent with the neuroprotective effects of AMPK signaling [208,209].”
Potential roles of gut microbiota and microbial metabolites in Parkinson’s disease
Zheng, S.-Y., Li, H.-X., Xu, R.-C., Miao, W.-T., Dai, M.-Y., Ding, S.-T., & Liu, H.-D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101347 · Cited by 101
Ruiz-Pozo, V. A., Tamayo-Trujillo, R., Cadena-Ullauri, S., Frias-Toral, E., Guevara-Ramírez, P., Paz-Cruz, E., Chapela, S., Montalván, M., Morales-López, T., Simancas-Racines, D., et al. (2023) · Nutrients · doi:10.3390/nu15163585 · Cited by 63
“Moreover, ghrelin can enhance several energy metabolic pathways like beta oxidation [133] and alleviate neuronal inflammation by reducing proinflammatory cytokines [134].”
BackgroundRusso, C., Valle, M. S., Russo, A., & Malaguarnera, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113432 · Cited by 40
Metadata
- Authors
- Reich, N., & Hölscher, C.
- Affiliations
- Lancaster University (GB)
- Henan University of Chinese Medicine (CN)
- Corresponding author
- Reich, Niklas
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2020-12-14
- Volume
- 14
- Pages
- 614828-614828
- ISSN
- 1662-453X (ISSN-L)
- PMC
- PMC7767977
- OpenAlex
- W3111850577
- Cited by
- 48
- References
- 476
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 7 · 2023: 9 · 2022: 13 · 2021: 6
- FWCI
- 0.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Neuroscience (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Lancaster EPrints (Lancaster University) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- acylated ghrelin, Alzheimer's disease, Parkinson's disease, neuroprotection, oxidative stress, mitochondrial dysfunction, autophagy, mitophagy, systemic inflammation, blood-brain barrier, dopamine depletion, neurogenesis, multi-target therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review